Cargando…
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
OBJECTIVE: To assess whether patients with aortic valve stenosis (AS) with elevated lipoprotein(a) (Lp(a)) are characterised by increased valvular calcification activity compared with those with low Lp(a). METHODS: We performed (18)F-sodium fluoride ((18)F-NaF) positron emission tomography/CT in pat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666821/ https://www.ncbi.nlm.nih.gov/pubmed/34593533 http://dx.doi.org/10.1136/heartjnl-2021-319804 |
_version_ | 1784614276625858560 |
---|---|
author | Kaiser, Yannick Nurmohamed, Nick S Kroon, Jeffrey Verberne, Hein J Tzolos, Evangelos Dweck, Marc R Somsen, Aernout G Arsenault, Benoit J Stroes, Erik S G Zheng, Kang H Boekholdt, S Matthijs |
author_facet | Kaiser, Yannick Nurmohamed, Nick S Kroon, Jeffrey Verberne, Hein J Tzolos, Evangelos Dweck, Marc R Somsen, Aernout G Arsenault, Benoit J Stroes, Erik S G Zheng, Kang H Boekholdt, S Matthijs |
author_sort | Kaiser, Yannick |
collection | PubMed |
description | OBJECTIVE: To assess whether patients with aortic valve stenosis (AS) with elevated lipoprotein(a) (Lp(a)) are characterised by increased valvular calcification activity compared with those with low Lp(a). METHODS: We performed (18)F-sodium fluoride ((18)F-NaF) positron emission tomography/CT in patients with mild to moderate AS (peak aortic jet velocity between 2 and 4 m/s) and high versus low Lp(a) (>50 mg/dL vs <50 mg/dL, respectively). Subjects were matched according to age, gender, peak aortic jet velocity and valve morphology. We used a target to background ratio with the most diseased segment approach to compare (18)F-NaF uptake. RESULTS: 52 individuals (26 matched pairs) were included in the analysis. The mean age was 66.4±5.5 years, 44 (84.6%) were men, and the mean aortic valve velocity was 2.80±0.49 m/s. The median Lp(a) was 79 (64–117) mg/dL and 7 (5–11) mg/dL in the high and low Lp(a) groups, respectively. Systolic blood pressure and low-density-lipoprotein cholesterol (corrected for Lp(a)) were significantly higher in the low Lp(a) group (141±12 mm Hg vs 128±12 mm Hg, 2.5±1.1 mmol/L vs 1.9±0.8 mmol/L). We found no difference in valvular (18)F-NaF uptake between the high and low Lp(a) groups (3.02±1.26 vs 3.05±0.96, p=0.902). Linear regression analysis showed valvular calcium score to be the only significant determinant of valvular (18)F-NaF uptake (β=0.63; 95% CI 0.38 to 0.88 per 1000 Agatston unit increase, p<0.001). Lp(a) was not associated with (18)F-NaF uptake (β=0.17; 95% CI −0.44 to 0.88, p=0.305 for the high Lp(a) group). CONCLUSION: Among patients with mild to moderate AS, calcification activity is predominantly determined by established calcium burden. The results do not support our hypothesis that Lp(a) is associated with valvular (18)F-NaF uptake. |
format | Online Article Text |
id | pubmed-8666821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-86668212021-12-28 Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis Kaiser, Yannick Nurmohamed, Nick S Kroon, Jeffrey Verberne, Hein J Tzolos, Evangelos Dweck, Marc R Somsen, Aernout G Arsenault, Benoit J Stroes, Erik S G Zheng, Kang H Boekholdt, S Matthijs Heart Valvular Heart Disease OBJECTIVE: To assess whether patients with aortic valve stenosis (AS) with elevated lipoprotein(a) (Lp(a)) are characterised by increased valvular calcification activity compared with those with low Lp(a). METHODS: We performed (18)F-sodium fluoride ((18)F-NaF) positron emission tomography/CT in patients with mild to moderate AS (peak aortic jet velocity between 2 and 4 m/s) and high versus low Lp(a) (>50 mg/dL vs <50 mg/dL, respectively). Subjects were matched according to age, gender, peak aortic jet velocity and valve morphology. We used a target to background ratio with the most diseased segment approach to compare (18)F-NaF uptake. RESULTS: 52 individuals (26 matched pairs) were included in the analysis. The mean age was 66.4±5.5 years, 44 (84.6%) were men, and the mean aortic valve velocity was 2.80±0.49 m/s. The median Lp(a) was 79 (64–117) mg/dL and 7 (5–11) mg/dL in the high and low Lp(a) groups, respectively. Systolic blood pressure and low-density-lipoprotein cholesterol (corrected for Lp(a)) were significantly higher in the low Lp(a) group (141±12 mm Hg vs 128±12 mm Hg, 2.5±1.1 mmol/L vs 1.9±0.8 mmol/L). We found no difference in valvular (18)F-NaF uptake between the high and low Lp(a) groups (3.02±1.26 vs 3.05±0.96, p=0.902). Linear regression analysis showed valvular calcium score to be the only significant determinant of valvular (18)F-NaF uptake (β=0.63; 95% CI 0.38 to 0.88 per 1000 Agatston unit increase, p<0.001). Lp(a) was not associated with (18)F-NaF uptake (β=0.17; 95% CI −0.44 to 0.88, p=0.305 for the high Lp(a) group). CONCLUSION: Among patients with mild to moderate AS, calcification activity is predominantly determined by established calcium burden. The results do not support our hypothesis that Lp(a) is associated with valvular (18)F-NaF uptake. BMJ Publishing Group 2022-01 2021-09-30 /pmc/articles/PMC8666821/ /pubmed/34593533 http://dx.doi.org/10.1136/heartjnl-2021-319804 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Valvular Heart Disease Kaiser, Yannick Nurmohamed, Nick S Kroon, Jeffrey Verberne, Hein J Tzolos, Evangelos Dweck, Marc R Somsen, Aernout G Arsenault, Benoit J Stroes, Erik S G Zheng, Kang H Boekholdt, S Matthijs Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis |
title | Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis |
title_full | Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis |
title_fullStr | Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis |
title_full_unstemmed | Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis |
title_short | Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis |
title_sort | lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis |
topic | Valvular Heart Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666821/ https://www.ncbi.nlm.nih.gov/pubmed/34593533 http://dx.doi.org/10.1136/heartjnl-2021-319804 |
work_keys_str_mv | AT kaiseryannick lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis AT nurmohamednicks lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis AT kroonjeffrey lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis AT verberneheinj lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis AT tzolosevangelos lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis AT dweckmarcr lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis AT somsenaernoutg lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis AT arsenaultbenoitj lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis AT stroeseriksg lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis AT zhengkangh lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis AT boekholdtsmatthijs lipoproteinahasnomajorimpactoncalcificationactivityinpatientswithmildtomoderateaorticvalvestenosis |